About the ICATT Program

Purpose

The ICATT program provides access to no-cost COVID-19 testing in U.S. communities to people that are uninsured and no-cost COVID-19 vaccines to people that are underinsured and uninsured. The program also supports surge testing in state and local jurisdictions. These surge sites provide expanded community testing in response to a sudden increase in COVID-19 transmission.

Vision and values

The ICATT program provides access to COVID-19 testing in US communities to people that are uninsured and are symptomatic or exposed. ICATT also supports surge testing in state and local jurisdictions.

CDC has modified existing ICATT testing contracts with CVS Health, Walgreens, and eTrueNorth to include no-cost COVID-19 vaccines for uninsured and underinsured adults. The CDC Bridge Access Program is providing updated COVID-19 vaccines to adults without health insurance and adults with insurance plans that do not cover all COVID-19 vaccine costs at in-network providers. No-cost COVID-19 vaccines through this program will end in August 2024. Many of the more than 22,000 sites that are offering no-cost vaccines are also offering no-cost COVID-19 testing services and will continue to offer no-cost COVID-19 testing services to people without health insurance until December 31, 2024. Program extensions beyond this date will be announced on the ICATT website.

Types of tests offered under the ICATT program

COVID-19 tests offered vary by location and vendor. Test types include laboratory-based nucleic acid amplification tests (NAATs) and rapid antigen point-of-care (POC) tests. Both types of tests can tell you if you have COVID-19. People typically receive their test results the same day or the day after getting tested.

Where services are offered

The ICATT program selects testing sites based on the Rural-Urban Commuting Areas (RUCA), CDC/ATSDR Social Vulnerability Index (SVI), and vendor pricing. Visit the CDC COVID-19 Testing Locator website to find a no-cost testing location with the vendors below.

Following the expiration of the COVID-19 public health emergency, the CDC ICATT strategy includes maintaining smaller vendor testing networks with the structural capacity to rapidly respond to a public health emergency and ongoing vendor contractual agreements to provide testing and vaccine services to people without health insurance.

What happens during a surge of COVID-19

The ICATT program works with testing vendors to increase availability of testing services when there is a surge in testing demand. Additionally, ICATT can coordinate with state and local public health agencies, federal partners, and ICATT testing vendors to provide no-cost and short-term COVID-19 surge testing sites to socially vulnerable communities.

How the partnership works

The ICATT mission focuses on providing no-cost COVID-19 testing and vaccines to individuals that are underinsured and uninsured. ICATT pharmacy sites provide vaccine services, while a subset of ICATT pharmacy sites provide both testing and vaccine services. All sites offering vaccine services are open to the public regardless of insurance status.

ICATT pharmacy sites:

  • schedule appointments
  • register patients for testing and vaccines
  • collect patient samples
  • process tests
  • report results to individuals and public health entities
  • administer vaccines
Print
Content Source:
Centers for Disease Control and Prevention